GLP-1 / Metabolic
Tirz-2
GLP-1 / GIP Dual Agonist
$89.00
Size
9 in stock · 10mg per vial
Description
Dual GLP-1 and GIP receptor agonist. Widely studied for glycemic control and metabolic research applications.
Research
Tirzepatide is a dual GLP-1 and GIP receptor agonist engineered as a single synthetic peptide. Research demonstrates that co-activation of both incretin receptors produces synergistic effects on insulin secretion, glucagon suppression, and weight reduction beyond what GLP-1 agonism alone achieves. Preclinical studies show significant reductions in adiposity, hepatic steatosis, and inflammatory markers. Clinical research has documented substantial HbA1c reductions and body weight loss in type 2 diabetes models. Mechanistic studies suggest GIP receptor activation may enhance the tolerability of GLP-1-mediated effects and contribute to adipose tissue remodeling. Research into cardiovascular outcomes, renal protection, and sleep apnea is ongoing. For research use only.
RESEARCH USE ONLY. Not for human or veterinary consumption. This product is sold to qualified researchers aged 21 or older for laboratory research purposes.